This inventor holds 3 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1991-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1996
Title: Kyozo Hayashi: Innovator in Aromatic Amide Compounds
Introduction
Kyozo Hayashi is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of chemistry, particularly in the development of aromatic amide compounds. With a total of 3 patents to his name, Hayashi continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Hayashi's latest patents include groundbreaking work on aromatic amide compounds and their production and use. These compounds are characterized by the formula: ##STR1##, where R.sub.1, R.sub.2, and R.sub.3 can be independently hydrogen, a lower alkyl, or lower alkoxy group, and Ar represents an optionally substituted aromatic group. Additionally, he has developed a novel polypeptide composed of 60 amino acids, with an N-terminus of EAQ. This polypeptide is produced from human breast cancer cell lines such as MCF7, as well as human gastric cancer cell lines MKN-45 and KATO-III. It has an isoelectric point of 4.3 and a molecular weight of 6,661.
Career Highlights
Kyozo Hayashi is currently associated with Takeda Chemical Industries, Inc., where he applies his expertise in chemistry to advance the company's research and development initiatives. His work has been instrumental in creating innovative solutions that address various challenges in the pharmaceutical industry.
Collaborations
Hayashi has collaborated with esteemed colleagues such as Giichi Goto and Munekazu Iinuma. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Kyozo Hayashi is a distinguished inventor whose work in aromatic amide compounds and polypeptides has made a significant impact in the field of chemistry. His contributions continue to inspire innovation and advancement in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
